David I. Lieberman

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A3 Adenosine Receptors: Affinity Enhancement by N6-(2-Phenylethyl) Substitution”.

Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A3 Adenosine Receptors: Affinity Enhancement by N6-(2-Phenylethyl) Substitution

Journal of Medicinal Chemistry(2020)10.1021/acs.jmedchem.0c00235

N/A

0DataRank · unranked

20 citations

Veronica Salmaso, Harsha Rao, Amelia Bitant, Courtney Fisher, David I. Lieberman +7 more

Structure–Activity Relationship of Heterocyclic P2Y14 Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00164

N/A

0DataRank · unranked

20 citations

Veronica Salmaso, Zhiwei Wen, John M. Bennett, Ngan B. Phung, David I. Lieberman +8 more

Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2Y14R Antagonist

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.1c01964

N/A

0DataRank · unranked

16 citations

Veronica Salmaso, Kwan‐Young Jung, Ngan B. Phung, Varun Gopinatth, Qasim Shah +10 more